Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma

BackgroundProficient mismatch repair (pMMR) colorectal adenocarcinoma (CRAC) metastasizes to a greater extent than MMR-deficient CRAC. Prognostic biomarkers are preferred in clinical practice. However, traditional biomarkers screened directly from sequencing are often not robust and thus cannot be c...

Full description

Bibliographic Details
Main Authors: Yixi Li, Dehua Li, Yang Chen, Yongping Lu, Fangbin Zhou, Chunhong Li, Zhipeng Zeng, Wanxia Cai, Liewen Lin, Qiang Li, Mingjun Ye, Jingjing Dong, Lianghong Yin, Donge Tang, Gong Zhang, Yong Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
colorectal cancer
mismatch repair
glycosylation
glycogene
ceRNA
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.727752/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.727752/full

Similar Items